| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitragyna | 11 | 2021 | 15 | 2.520 |
Why?
|
| Toxicology | 6 | 2020 | 106 | 2.150 |
Why?
|
| Analgesics, Opioid | 25 | 2023 | 3674 | 2.140 |
Why?
|
| Narcotic Antagonists | 10 | 2020 | 562 | 1.760 |
Why?
|
| Biosensing Techniques | 6 | 2017 | 668 | 1.610 |
Why?
|
| Poisoning | 9 | 2015 | 249 | 1.520 |
Why?
|
| Substance Abuse Detection | 5 | 2017 | 283 | 1.500 |
Why?
|
| Oxycodone | 4 | 2022 | 153 | 1.470 |
Why?
|
| Substance-Related Disorders | 17 | 2022 | 4259 | 1.430 |
Why?
|
| Naloxone | 9 | 2020 | 367 | 1.370 |
Why?
|
| Secologanin Tryptamine Alkaloids | 5 | 2021 | 8 | 1.160 |
Why?
|
| Narcotics | 2 | 2018 | 343 | 1.040 |
Why?
|
| Monitoring, Ambulatory | 4 | 2016 | 355 | 1.000 |
Why?
|
| Opioid-Related Disorders | 9 | 2020 | 2065 | 0.950 |
Why?
|
| Buprenorphine | 4 | 2018 | 640 | 0.940 |
Why?
|
| Music Therapy | 3 | 2020 | 102 | 0.880 |
Why?
|
| Methadone | 2 | 2018 | 306 | 0.850 |
Why?
|
| Medication Adherence | 11 | 2023 | 2062 | 0.830 |
Why?
|
| Acetaminophen | 6 | 2022 | 545 | 0.810 |
Why?
|
| Plant Extracts | 8 | 2021 | 472 | 0.800 |
Why?
|
| Internet | 12 | 2018 | 3063 | 0.800 |
Why?
|
| Emergency Service, Hospital | 21 | 2024 | 7659 | 0.790 |
Why?
|
| Anti-HIV Agents | 9 | 2023 | 4256 | 0.770 |
Why?
|
| Faculty, Medical | 2 | 2020 | 1181 | 0.770 |
Why?
|
| Wireless Technology | 3 | 2020 | 99 | 0.760 |
Why?
|
| Dextromethorphan | 3 | 2007 | 38 | 0.760 |
Why?
|
| Drug Contamination | 3 | 2017 | 148 | 0.740 |
Why?
|
| Antidotes | 6 | 2015 | 138 | 0.710 |
Why?
|
| Dioxins | 1 | 2020 | 102 | 0.700 |
Why?
|
| Plant Preparations | 2 | 2011 | 94 | 0.680 |
Why?
|
| DNA Methylation | 4 | 2021 | 4289 | 0.670 |
Why?
|
| Cannabidiol | 1 | 2020 | 106 | 0.660 |
Why?
|
| Tobacco, Smokeless | 1 | 2019 | 130 | 0.640 |
Why?
|
| Fentanyl | 3 | 2017 | 410 | 0.640 |
Why?
|
| Serotonin Syndrome | 3 | 2011 | 18 | 0.600 |
Why?
|
| Cellulitis | 1 | 2019 | 206 | 0.600 |
Why?
|
| Substance Withdrawal Syndrome | 4 | 2019 | 632 | 0.590 |
Why?
|
| Calcium Channel Blockers | 4 | 2007 | 690 | 0.590 |
Why?
|
| Drug and Narcotic Control | 3 | 2019 | 146 | 0.580 |
Why?
|
| Glass | 1 | 2017 | 114 | 0.580 |
Why?
|
| Cultural Diversity | 1 | 2020 | 359 | 0.570 |
Why?
|
| Mouth Mucosa | 1 | 2019 | 434 | 0.560 |
Why?
|
| Writing | 1 | 2018 | 206 | 0.560 |
Why?
|
| Spermatozoa | 1 | 2020 | 625 | 0.540 |
Why?
|
| Enterocolitis, Pseudomembranous | 2 | 2016 | 264 | 0.540 |
Why?
|
| Radio Frequency Identification Device | 1 | 2015 | 21 | 0.540 |
Why?
|
| Medical Informatics Applications | 1 | 2017 | 186 | 0.540 |
Why?
|
| Transducers | 1 | 2017 | 252 | 0.530 |
Why?
|
| Phytotherapy | 2 | 2008 | 298 | 0.530 |
Why?
|
| Psychotropic Drugs | 4 | 2020 | 894 | 0.530 |
Why?
|
| Methanol | 2 | 2008 | 85 | 0.520 |
Why?
|
| Attitude to Computers | 2 | 2015 | 202 | 0.520 |
Why?
|
| Efficiency | 1 | 2018 | 462 | 0.510 |
Why?
|
| Fractures, Bone | 2 | 2017 | 1947 | 0.510 |
Why?
|
| Systems Integration | 1 | 2017 | 440 | 0.510 |
Why?
|
| Tendons | 1 | 2019 | 548 | 0.500 |
Why?
|
| Opiate Substitution Treatment | 1 | 2018 | 404 | 0.490 |
Why?
|
| HIV Infections | 13 | 2023 | 16718 | 0.490 |
Why?
|
| Physostigmine | 2 | 2006 | 53 | 0.480 |
Why?
|
| Humans | 152 | 2024 | 744220 | 0.460 |
Why?
|
| Schools, Medical | 1 | 2020 | 878 | 0.460 |
Why?
|
| Hydroquinones | 1 | 2013 | 36 | 0.460 |
Why?
|
| Drainage | 1 | 2019 | 1141 | 0.460 |
Why?
|
| Cocaine-Related Disorders | 2 | 2015 | 460 | 0.450 |
Why?
|
| Videoconferencing | 1 | 2015 | 195 | 0.450 |
Why?
|
| Telemedicine | 5 | 2021 | 2872 | 0.450 |
Why?
|
| Sodium Oxybate | 2 | 2004 | 32 | 0.430 |
Why?
|
| Remote Consultation | 1 | 2015 | 238 | 0.430 |
Why?
|
| Apnea | 1 | 2014 | 195 | 0.430 |
Why?
|
| Cyclohexylamines | 1 | 2011 | 21 | 0.410 |
Why?
|
| Cyclohexanones | 1 | 2011 | 30 | 0.410 |
Why?
|
| beta-Alanine | 1 | 2011 | 74 | 0.400 |
Why?
|
| Cannabis | 4 | 2020 | 438 | 0.400 |
Why?
|
| Acetylcysteine | 3 | 2019 | 272 | 0.390 |
Why?
|
| Receptors, Opioid | 2 | 2011 | 155 | 0.390 |
Why?
|
| Capsules | 3 | 2019 | 197 | 0.390 |
Why?
|
| Male | 82 | 2024 | 350027 | 0.390 |
Why?
|
| Self Medication | 2 | 2009 | 117 | 0.390 |
Why?
|
| Violence | 4 | 2019 | 909 | 0.390 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 1180 | 0.380 |
Why?
|
| Diarrhea | 2 | 2016 | 1347 | 0.380 |
Why?
|
| Research Support as Topic | 2 | 2018 | 704 | 0.380 |
Why?
|
| Hyperinsulinism | 2 | 2006 | 415 | 0.380 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2019 | 1269 | 0.370 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2015 | 720 | 0.360 |
Why?
|
| Malignant Hyperthermia | 1 | 2010 | 73 | 0.360 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2011 | 144 | 0.360 |
Why?
|
| Secondary Prevention | 1 | 2016 | 1531 | 0.350 |
Why?
|
| Ondansetron | 1 | 2010 | 89 | 0.350 |
Why?
|
| Nasopharynx | 1 | 2012 | 379 | 0.350 |
Why?
|
| Galvanic Skin Response | 3 | 2016 | 349 | 0.350 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2010 | 102 | 0.340 |
Why?
|
| Marijuana Smoking | 3 | 2017 | 253 | 0.340 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2010 | 176 | 0.340 |
Why?
|
| Hallucinogens | 2 | 2020 | 183 | 0.340 |
Why?
|
| Color Vision | 1 | 2009 | 21 | 0.340 |
Why?
|
| Construction Materials | 1 | 2009 | 60 | 0.330 |
Why?
|
| Adult | 56 | 2023 | 214035 | 0.330 |
Why?
|
| Antithrombins | 1 | 2011 | 304 | 0.330 |
Why?
|
| Polyurethanes | 1 | 2009 | 107 | 0.320 |
Why?
|
| Rubiaceae | 1 | 2008 | 2 | 0.320 |
Why?
|
| Antiemetics | 1 | 2010 | 176 | 0.320 |
Why?
|
| Salvia | 1 | 2008 | 14 | 0.320 |
Why?
|
| Accidents, Home | 1 | 2008 | 75 | 0.320 |
Why?
|
| Organizational Policy | 3 | 2005 | 427 | 0.320 |
Why?
|
| Cyanoacrylates | 1 | 2008 | 49 | 0.320 |
Why?
|
| Chlorpheniramine | 1 | 2007 | 13 | 0.320 |
Why?
|
| Hydromorphone | 1 | 2008 | 65 | 0.320 |
Why?
|
| Anti-Bacterial Agents | 5 | 2020 | 7179 | 0.320 |
Why?
|
| Phenylpropanolamine | 1 | 2007 | 15 | 0.320 |
Why?
|
| Pilot Projects | 10 | 2022 | 8321 | 0.310 |
Why?
|
| Adhesives | 1 | 2008 | 61 | 0.310 |
Why?
|
| Dietary Supplements | 5 | 2016 | 3297 | 0.310 |
Why?
|
| Acidosis | 2 | 2011 | 272 | 0.310 |
Why?
|
| Molecular Biology | 1 | 2011 | 596 | 0.310 |
Why?
|
| Status Epilepticus | 1 | 2013 | 444 | 0.310 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 2218 | 0.300 |
Why?
|
| Mentors | 3 | 2020 | 630 | 0.300 |
Why?
|
| Ethylene Glycol | 2 | 2012 | 29 | 0.300 |
Why?
|
| Music | 2 | 2020 | 263 | 0.300 |
Why?
|
| Pain | 4 | 2020 | 4987 | 0.290 |
Why?
|
| Monoamine Oxidase Inhibitors | 2 | 2005 | 158 | 0.290 |
Why?
|
| Homosexuality, Male | 7 | 2022 | 1240 | 0.290 |
Why?
|
| Pharmaceutical Services | 1 | 2008 | 140 | 0.290 |
Why?
|
| Peer Review, Research | 1 | 2010 | 329 | 0.290 |
Why?
|
| Radio Waves | 2 | 2019 | 251 | 0.280 |
Why?
|
| Benzimidazoles | 1 | 2011 | 851 | 0.280 |
Why?
|
| Emergency Medical Services | 7 | 2017 | 1916 | 0.280 |
Why?
|
| Drug Labeling | 1 | 2008 | 232 | 0.280 |
Why?
|
| Diazepam | 3 | 2020 | 205 | 0.270 |
Why?
|
| Behavior, Addictive | 1 | 2011 | 462 | 0.270 |
Why?
|
| Health Facility Administration | 1 | 2005 | 31 | 0.270 |
Why?
|
| Skin Temperature | 2 | 2016 | 94 | 0.270 |
Why?
|
| Environmental Exposure | 1 | 2020 | 4236 | 0.260 |
Why?
|
| Ofloxacin | 1 | 2005 | 65 | 0.260 |
Why?
|
| Glucose Clamp Technique | 1 | 2006 | 266 | 0.260 |
Why?
|
| Female | 57 | 2024 | 380197 | 0.260 |
Why?
|
| Telemetry | 2 | 2017 | 205 | 0.260 |
Why?
|
| Vancomycin | 1 | 2008 | 501 | 0.260 |
Why?
|
| Adolescent | 32 | 2023 | 85759 | 0.260 |
Why?
|
| Seizures | 3 | 2013 | 2859 | 0.250 |
Why?
|
| Methoxydimethyltryptamines | 1 | 2004 | 2 | 0.240 |
Why?
|
| Harmaline | 1 | 2004 | 4 | 0.240 |
Why?
|
| Deception | 2 | 2004 | 99 | 0.240 |
Why?
|
| Cannabinoids | 2 | 2017 | 166 | 0.240 |
Why?
|
| Pyrazoles | 4 | 2012 | 1973 | 0.240 |
Why?
|
| Recreation | 2 | 2017 | 115 | 0.240 |
Why?
|
| Bronchi | 1 | 2008 | 840 | 0.240 |
Why?
|
| Renal Dialysis | 5 | 2011 | 1787 | 0.240 |
Why?
|
| Wrist | 2 | 2016 | 225 | 0.240 |
Why?
|
| Antibodies, Viral | 3 | 2021 | 3176 | 0.230 |
Why?
|
| Respiratory Insufficiency | 3 | 2008 | 1199 | 0.230 |
Why?
|
| Referral and Consultation | 2 | 2020 | 3528 | 0.230 |
Why?
|
| Infusions, Intravenous | 5 | 2014 | 2272 | 0.230 |
Why?
|
| Self Report | 4 | 2019 | 3558 | 0.230 |
Why?
|
| Occupational Diseases | 2 | 2009 | 1472 | 0.230 |
Why?
|
| Middle Aged | 36 | 2022 | 213367 | 0.220 |
Why?
|
| Chromatography, Liquid | 2 | 2017 | 977 | 0.220 |
Why?
|
| Airway Obstruction | 1 | 2008 | 663 | 0.220 |
Why?
|
| Self Care | 2 | 2011 | 786 | 0.220 |
Why?
|
| Head | 1 | 2008 | 880 | 0.220 |
Why?
|
| Heroin | 2 | 2017 | 117 | 0.220 |
Why?
|
| Feasibility Studies | 6 | 2022 | 5076 | 0.220 |
Why?
|
| Peer Group | 2 | 2019 | 635 | 0.220 |
Why?
|
| Bromides | 1 | 2002 | 20 | 0.210 |
Why?
|
| Bradycardia | 1 | 2004 | 305 | 0.210 |
Why?
|
| Hydrocodone | 1 | 2022 | 47 | 0.210 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 10182 | 0.210 |
Why?
|
| Trachea | 1 | 2008 | 1075 | 0.210 |
Why?
|
| Aged | 30 | 2024 | 163253 | 0.210 |
Why?
|
| Occupational Exposure | 3 | 2012 | 1796 | 0.210 |
Why?
|
| Medication Errors | 1 | 2008 | 797 | 0.210 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2020 | 780 | 0.210 |
Why?
|
| Skin | 2 | 2015 | 4363 | 0.210 |
Why?
|
| Cocaine | 3 | 2015 | 1007 | 0.210 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2015 | 3923 | 0.200 |
Why?
|
| Vision Disorders | 1 | 2009 | 1059 | 0.200 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 3842 | 0.200 |
Why?
|
| Young Adult | 19 | 2022 | 56436 | 0.200 |
Why?
|
| Propofol | 1 | 2007 | 628 | 0.200 |
Why?
|
| Emergencies | 2 | 2013 | 1170 | 0.200 |
Why?
|
| Information Dissemination | 2 | 2007 | 1100 | 0.190 |
Why?
|
| Research Design | 1 | 2017 | 5987 | 0.190 |
Why?
|
| Hemorrhage | 2 | 2018 | 3461 | 0.190 |
Why?
|
| Morphine Dependence | 1 | 2020 | 31 | 0.190 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2001 | 65 | 0.190 |
Why?
|
| Pulmonary Edema | 1 | 2023 | 414 | 0.190 |
Why?
|
| Drug Combinations | 3 | 2012 | 1962 | 0.190 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2020 | 57 | 0.180 |
Why?
|
| Vietnam Conflict | 1 | 2020 | 99 | 0.180 |
Why?
|
| Flavoring Agents | 1 | 2020 | 52 | 0.180 |
Why?
|
| Vital Signs | 1 | 2021 | 141 | 0.180 |
Why?
|
| Biomedical Research | 2 | 2020 | 3311 | 0.180 |
Why?
|
| Health Education | 1 | 2007 | 1055 | 0.180 |
Why?
|
| Visual Acuity | 1 | 2009 | 2530 | 0.180 |
Why?
|
| Vitamin B 6 | 1 | 2021 | 237 | 0.180 |
Why?
|
| Therapeutic Irrigation | 2 | 2019 | 301 | 0.180 |
Why?
|
| Hydroxychloroquine | 2 | 2020 | 412 | 0.170 |
Why?
|
| Patient Compliance | 1 | 2010 | 2684 | 0.170 |
Why?
|
| Receptors, Opioid, mu | 1 | 2020 | 182 | 0.170 |
Why?
|
| Toilet Facilities | 1 | 2019 | 26 | 0.170 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 1161 | 0.170 |
Why?
|
| Pain Measurement | 5 | 2022 | 3419 | 0.170 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2019 | 42 | 0.170 |
Why?
|
| Charcoal | 1 | 2019 | 63 | 0.170 |
Why?
|
| Thoracostomy | 1 | 2019 | 72 | 0.170 |
Why?
|
| Hospitals | 4 | 2021 | 3952 | 0.170 |
Why?
|
| Therapeutic Equivalency | 1 | 2019 | 145 | 0.170 |
Why?
|
| Polypharmacy | 1 | 2021 | 294 | 0.170 |
Why?
|
| Bicycling | 1 | 2020 | 176 | 0.170 |
Why?
|
| Tea | 1 | 2020 | 275 | 0.170 |
Why?
|
| Affect | 2 | 2017 | 1475 | 0.170 |
Why?
|
| Fatal Outcome | 4 | 2017 | 1849 | 0.160 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2018 | 67 | 0.160 |
Why?
|
| Resins, Plant | 1 | 2017 | 20 | 0.160 |
Why?
|
| Hypernatremia | 1 | 2018 | 82 | 0.160 |
Why?
|
| Hypotension | 1 | 2004 | 880 | 0.160 |
Why?
|
| Benzodiazepines | 2 | 2019 | 1101 | 0.160 |
Why?
|
| Career Mobility | 1 | 2020 | 262 | 0.160 |
Why?
|
| Equipment Design | 2 | 2017 | 3582 | 0.160 |
Why?
|
| Copper Sulfate | 1 | 2017 | 14 | 0.150 |
Why?
|
| Geographic Information Systems | 1 | 2020 | 281 | 0.150 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2003 | 738 | 0.150 |
Why?
|
| Poison Control Centers | 2 | 2014 | 72 | 0.150 |
Why?
|
| Chelation Therapy | 1 | 2017 | 67 | 0.150 |
Why?
|
| Pain Threshold | 2 | 2020 | 585 | 0.150 |
Why?
|
| Artificial Intelligence | 2 | 2021 | 2213 | 0.150 |
Why?
|
| Fractures, Open | 1 | 2018 | 101 | 0.150 |
Why?
|
| Thrombophilia | 1 | 2020 | 305 | 0.150 |
Why?
|
| Arsenic | 1 | 2020 | 328 | 0.150 |
Why?
|
| Heroin Dependence | 1 | 2017 | 175 | 0.140 |
Why?
|
| Methamphetamine | 1 | 2018 | 154 | 0.140 |
Why?
|
| Insulin | 2 | 2002 | 6583 | 0.140 |
Why?
|
| Designer Drugs | 1 | 2016 | 20 | 0.140 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2018 | 281 | 0.140 |
Why?
|
| Sexual Behavior | 2 | 2019 | 2056 | 0.140 |
Why?
|
| Plants, Edible | 1 | 2016 | 30 | 0.140 |
Why?
|
| Advance Care Planning | 1 | 2024 | 662 | 0.140 |
Why?
|
| Financing, Government | 1 | 2020 | 468 | 0.140 |
Why?
|
| Predictive Value of Tests | 5 | 2018 | 15070 | 0.140 |
Why?
|
| United States | 16 | 2020 | 69867 | 0.140 |
Why?
|
| Joints | 1 | 2018 | 326 | 0.140 |
Why?
|
| Accidents | 1 | 2017 | 164 | 0.140 |
Why?
|
| Malaysia | 3 | 2021 | 92 | 0.140 |
Why?
|
| Patient Care Team | 2 | 2018 | 2529 | 0.140 |
Why?
|
| Atrial Premature Complexes | 1 | 2015 | 17 | 0.140 |
Why?
|
| Aircraft | 1 | 2017 | 123 | 0.140 |
Why?
|
| Fingers | 1 | 2019 | 514 | 0.140 |
Why?
|
| Stomach Diseases | 1 | 2017 | 134 | 0.140 |
Why?
|
| Catheters | 1 | 2019 | 425 | 0.140 |
Why?
|
| Pneumothorax | 1 | 2019 | 379 | 0.130 |
Why?
|
| Drug Prescriptions | 2 | 2023 | 1637 | 0.130 |
Why?
|
| Nicotine | 1 | 2020 | 681 | 0.130 |
Why?
|
| Pain Perception | 1 | 2017 | 191 | 0.130 |
Why?
|
| Patient Satisfaction | 4 | 2023 | 3395 | 0.130 |
Why?
|
| Pulse | 1 | 2015 | 229 | 0.130 |
Why?
|
| Pregnancy Complications | 1 | 2010 | 2862 | 0.130 |
Why?
|
| Photoplethysmography | 1 | 2015 | 56 | 0.130 |
Why?
|
| Continuity of Patient Care | 2 | 2023 | 1049 | 0.130 |
Why?
|
| Multiple Trauma | 1 | 2018 | 367 | 0.130 |
Why?
|
| Depression | 4 | 2019 | 7767 | 0.130 |
Why?
|
| Automobile Driving | 1 | 2020 | 431 | 0.130 |
Why?
|
| Patient Care | 1 | 2021 | 640 | 0.130 |
Why?
|
| Data Mining | 1 | 2020 | 537 | 0.130 |
Why?
|
| Suicide, Attempted | 2 | 2020 | 1221 | 0.130 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2015 | 66 | 0.130 |
Why?
|
| Research Personnel | 1 | 2020 | 573 | 0.130 |
Why?
|
| Lung Injury | 1 | 2020 | 436 | 0.130 |
Why?
|
| Miosis | 1 | 2014 | 7 | 0.130 |
Why?
|
| Accidents, Traffic | 1 | 2020 | 819 | 0.120 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2021 | 1157 | 0.120 |
Why?
|
| Coloring Agents | 1 | 2017 | 566 | 0.120 |
Why?
|
| Hemagglutinins, Viral | 1 | 2014 | 67 | 0.120 |
Why?
|
| Ventricular Premature Complexes | 1 | 2015 | 111 | 0.120 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 8628 | 0.120 |
Why?
|
| Vascular System Injuries | 1 | 2018 | 250 | 0.120 |
Why?
|
| Intubation, Intratracheal | 2 | 2013 | 1357 | 0.120 |
Why?
|
| Folic Acid | 1 | 2021 | 1300 | 0.120 |
Why?
|
| Mass Casualty Incidents | 1 | 2017 | 183 | 0.120 |
Why?
|
| Delivery of Health Care | 4 | 2021 | 5319 | 0.120 |
Why?
|
| Delirium | 1 | 2006 | 1609 | 0.120 |
Why?
|
| Sodium Acetate | 1 | 2013 | 7 | 0.120 |
Why?
|
| Gastric Mucosa | 1 | 2017 | 599 | 0.120 |
Why?
|
| Gelatin | 1 | 2015 | 225 | 0.120 |
Why?
|
| Triage | 1 | 2021 | 976 | 0.120 |
Why?
|
| Point-of-Care Systems | 2 | 2019 | 1176 | 0.120 |
Why?
|
| Cell Adhesion Molecules | 1 | 2020 | 1602 | 0.120 |
Why?
|
| Locomotion | 1 | 2016 | 378 | 0.120 |
Why?
|
| Soft Tissue Infections | 1 | 2015 | 155 | 0.120 |
Why?
|
| Heart Rate | 2 | 2015 | 4092 | 0.120 |
Why?
|
| Biological Availability | 1 | 2014 | 396 | 0.110 |
Why?
|
| Emergency Medicine | 2 | 2020 | 1207 | 0.110 |
Why?
|
| Robotics | 1 | 2021 | 899 | 0.110 |
Why?
|
| Saliva | 1 | 2017 | 809 | 0.110 |
Why?
|
| Infant | 8 | 2023 | 35129 | 0.110 |
Why?
|
| Sodium | 1 | 2018 | 1623 | 0.110 |
Why?
|
| Prospective Studies | 13 | 2023 | 53280 | 0.110 |
Why?
|
| Walking | 1 | 2020 | 1180 | 0.110 |
Why?
|
| Respiratory Rate | 1 | 2014 | 162 | 0.110 |
Why?
|
| Radiography, Thoracic | 1 | 2019 | 1265 | 0.110 |
Why?
|
| Bullying | 1 | 2015 | 210 | 0.110 |
Why?
|
| Risk-Taking | 2 | 2012 | 986 | 0.110 |
Why?
|
| Administration, Intranasal | 1 | 2014 | 446 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 1613 | 0.110 |
Why?
|
| Injections, Intravenous | 2 | 2006 | 1420 | 0.110 |
Why?
|
| Minority Groups | 1 | 2020 | 1223 | 0.110 |
Why?
|
| Phenytoin | 1 | 2013 | 197 | 0.110 |
Why?
|
| Phenobarbital | 1 | 2013 | 192 | 0.110 |
Why?
|
| Massachusetts | 4 | 2016 | 8663 | 0.110 |
Why?
|
| Lorazepam | 1 | 2013 | 145 | 0.110 |
Why?
|
| Cross-Sectional Studies | 9 | 2023 | 25043 | 0.110 |
Why?
|
| Industry | 1 | 2014 | 365 | 0.110 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2017 | 1537 | 0.110 |
Why?
|
| Plant Leaves | 3 | 2019 | 143 | 0.110 |
Why?
|
| Burns | 1 | 2023 | 1815 | 0.100 |
Why?
|
| Medicine | 1 | 2020 | 946 | 0.100 |
Why?
|
| Mustard Gas | 1 | 2012 | 16 | 0.100 |
Why?
|
| Chemical Warfare Agents | 1 | 2012 | 21 | 0.100 |
Why?
|
| Insufflation | 1 | 2012 | 65 | 0.100 |
Why?
|
| Diffusion of Innovation | 1 | 2017 | 725 | 0.100 |
Why?
|
| Information Services | 2 | 2005 | 244 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3132 | 0.100 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3239 | 0.100 |
Why?
|
| Crime Victims | 1 | 2015 | 322 | 0.100 |
Why?
|
| Pandemics | 6 | 2021 | 8387 | 0.100 |
Why?
|
| Body Temperature | 1 | 2015 | 777 | 0.100 |
Why?
|
| Pneumonia | 1 | 2023 | 2134 | 0.100 |
Why?
|
| Motion | 1 | 2015 | 798 | 0.100 |
Why?
|
| Treatment Outcome | 7 | 2020 | 63119 | 0.100 |
Why?
|
| Blister | 1 | 2012 | 86 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2020 | 10949 | 0.100 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2016 | 525 | 0.100 |
Why?
|
| Clinical Protocols | 2 | 2010 | 1462 | 0.100 |
Why?
|
| Partial Thromboplastin Time | 1 | 2011 | 206 | 0.100 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 1583 | 0.100 |
Why?
|
| Ataxia | 1 | 2013 | 304 | 0.100 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 1483 | 0.100 |
Why?
|
| Disaster Planning | 1 | 2017 | 548 | 0.090 |
Why?
|
| Natural Language Processing | 1 | 2018 | 1040 | 0.090 |
Why?
|
| Triplets | 1 | 2010 | 43 | 0.090 |
Why?
|
| Ultrasonography | 2 | 2023 | 5982 | 0.090 |
Why?
|
| Prescriptions | 2 | 2023 | 387 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 2204 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 17449 | 0.090 |
Why?
|
| Electronics | 2 | 2022 | 322 | 0.090 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 57768 | 0.090 |
Why?
|
| Veterans | 2 | 2021 | 2519 | 0.090 |
Why?
|
| Adolescent Behavior | 1 | 2018 | 1151 | 0.090 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2019 | 2540 | 0.090 |
Why?
|
| Hospital Administration | 2 | 2005 | 353 | 0.090 |
Why?
|
| Dementia | 1 | 2024 | 2518 | 0.090 |
Why?
|
| Risk Factors | 12 | 2022 | 72280 | 0.090 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 2875 | 0.090 |
Why?
|
| Volatilization | 1 | 2009 | 82 | 0.090 |
Why?
|
| Eye Protective Devices | 1 | 2009 | 33 | 0.090 |
Why?
|
| Anisocoria | 1 | 2008 | 10 | 0.090 |
Why?
|
| Physical Therapy Modalities | 1 | 2013 | 550 | 0.080 |
Why?
|
| Respiratory Protective Devices | 1 | 2009 | 45 | 0.080 |
Why?
|
| Glucose | 1 | 2001 | 4396 | 0.080 |
Why?
|
| Home Infusion Therapy | 1 | 2008 | 19 | 0.080 |
Why?
|
| Neoplasms | 3 | 2023 | 21672 | 0.080 |
Why?
|
| Drug Packaging | 1 | 2008 | 39 | 0.080 |
Why?
|
| Drug Interactions | 2 | 2005 | 1458 | 0.080 |
Why?
|
| Reproducibility of Results | 5 | 2021 | 19907 | 0.080 |
Why?
|
| Acid-Base Imbalance | 1 | 2008 | 41 | 0.080 |
Why?
|
| Protective Clothing | 1 | 2009 | 102 | 0.080 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2016 | 1036 | 0.080 |
Why?
|
| Sex Factors | 2 | 2020 | 10396 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2020 | 3023 | 0.080 |
Why?
|
| Social Support | 1 | 2018 | 2117 | 0.080 |
Why?
|
| Hospitalization | 2 | 2005 | 10262 | 0.080 |
Why?
|
| Twins, Monozygotic | 1 | 2010 | 458 | 0.080 |
Why?
|
| Retrospective Studies | 12 | 2023 | 77426 | 0.080 |
Why?
|
| Algorithms | 4 | 2018 | 13885 | 0.080 |
Why?
|
| Self Administration | 1 | 2009 | 386 | 0.080 |
Why?
|
| Diterpenes, Clerodane | 1 | 2008 | 43 | 0.080 |
Why?
|
| Child, Preschool | 7 | 2023 | 40992 | 0.080 |
Why?
|
| Diseases in Twins | 1 | 2010 | 450 | 0.080 |
Why?
|
| Systems Biology | 1 | 2011 | 469 | 0.080 |
Why?
|
| Necrosis | 1 | 2012 | 1643 | 0.080 |
Why?
|
| Nitrogen Isotopes | 1 | 2007 | 84 | 0.080 |
Why?
|
| Forecasting | 1 | 2017 | 2949 | 0.080 |
Why?
|
| Viscosity | 1 | 2008 | 328 | 0.080 |
Why?
|
| Alcoholism | 2 | 2008 | 1906 | 0.080 |
Why?
|
| Nitrogen Oxides | 1 | 2007 | 129 | 0.080 |
Why?
|
| Bicarbonates | 1 | 2008 | 313 | 0.080 |
Why?
|
| Immunoglobulin G | 3 | 2021 | 4559 | 0.080 |
Why?
|
| Medical Informatics | 1 | 2014 | 743 | 0.080 |
Why?
|
| Iridium Radioisotopes | 1 | 2006 | 26 | 0.070 |
Why?
|
| Radioactive Hazard Release | 1 | 2006 | 14 | 0.070 |
Why?
|
| Internship and Residency | 2 | 2019 | 5787 | 0.070 |
Why?
|
| Lyme Neuroborreliosis | 1 | 2007 | 51 | 0.070 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 1670 | 0.070 |
Why?
|
| Diltiazem | 1 | 2007 | 133 | 0.070 |
Why?
|
| Diterpenes | 1 | 2008 | 173 | 0.070 |
Why?
|
| Focus Groups | 1 | 2012 | 1321 | 0.070 |
Why?
|
| Aspirin | 1 | 2019 | 3282 | 0.070 |
Why?
|
| Gene Expression | 1 | 2020 | 7799 | 0.070 |
Why?
|
| Verapamil | 1 | 2007 | 244 | 0.070 |
Why?
|
| Vomiting | 1 | 2010 | 635 | 0.070 |
Why?
|
| Education, Medical | 1 | 2018 | 1721 | 0.070 |
Why?
|
| Respiratory Tract Infections | 1 | 2014 | 961 | 0.070 |
Why?
|
| Respiration, Artificial | 2 | 2008 | 2569 | 0.070 |
Why?
|
| Administration, Oral | 1 | 2014 | 3913 | 0.070 |
Why?
|
| Graft vs Host Disease | 1 | 2019 | 2957 | 0.070 |
Why?
|
| Child | 9 | 2023 | 77679 | 0.070 |
Why?
|
| Aerosols | 1 | 2009 | 623 | 0.070 |
Why?
|
| Nitrates | 1 | 2007 | 265 | 0.070 |
Why?
|
| Eating | 1 | 2013 | 1538 | 0.070 |
Why?
|
| Health Literacy | 1 | 2011 | 414 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2019 | 40559 | 0.070 |
Why?
|
| Borrelia burgdorferi | 1 | 2007 | 180 | 0.070 |
Why?
|
| Acetylcholinesterase | 1 | 2006 | 153 | 0.070 |
Why?
|
| Drug Utilization | 1 | 2012 | 1183 | 0.070 |
Why?
|
| Software | 2 | 2021 | 4442 | 0.070 |
Why?
|
| Aging | 2 | 2021 | 8661 | 0.070 |
Why?
|
| Butylene Glycols | 1 | 2005 | 10 | 0.070 |
Why?
|
| Boston | 3 | 2021 | 9311 | 0.060 |
Why?
|
| Arsenic Poisoning | 1 | 2005 | 55 | 0.060 |
Why?
|
| Physicians | 1 | 2023 | 4564 | 0.060 |
Why?
|
| Hydroxybutyrates | 1 | 2005 | 83 | 0.060 |
Why?
|
| Exercise | 1 | 2021 | 5615 | 0.060 |
Why?
|
| Herbicides | 1 | 2005 | 100 | 0.060 |
Why?
|
| Pharmacy Service, Hospital | 1 | 2005 | 133 | 0.060 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2008 | 365 | 0.060 |
Why?
|
| Demography | 1 | 2009 | 1656 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 8037 | 0.060 |
Why?
|
| Plants, Toxic | 1 | 2004 | 76 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 6352 | 0.060 |
Why?
|
| Pancreatic Neoplasms | 1 | 2021 | 5257 | 0.060 |
Why?
|
| Seeds | 1 | 2004 | 105 | 0.060 |
Why?
|
| Clinical Competence | 1 | 2019 | 4687 | 0.060 |
Why?
|
| Patient Selection | 2 | 2020 | 4216 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2019 | 4440 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2008 | 1907 | 0.060 |
Why?
|
| Muscle Relaxants, Central | 1 | 2003 | 86 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2013 | 1917 | 0.060 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 1404 | 0.060 |
Why?
|
| Metabolomics | 1 | 2011 | 1483 | 0.060 |
Why?
|
| Prevalence | 5 | 2020 | 15226 | 0.060 |
Why?
|
| Commerce | 1 | 2008 | 592 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2014 | 1480 | 0.050 |
Why?
|
| Organophosphorus Compounds | 1 | 2003 | 215 | 0.050 |
Why?
|
| Urologic Diseases | 1 | 2005 | 244 | 0.050 |
Why?
|
| Bronchoscopy | 1 | 2008 | 862 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2007 | 1538 | 0.050 |
Why?
|
| Drug Information Services | 1 | 2002 | 51 | 0.050 |
Why?
|
| Attitude | 1 | 2007 | 774 | 0.050 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2011 | 2234 | 0.050 |
Why?
|
| Insecticides | 1 | 2003 | 195 | 0.050 |
Why?
|
| Consciousness Disorders | 1 | 2006 | 418 | 0.050 |
Why?
|
| Barbiturates | 1 | 2002 | 114 | 0.050 |
Why?
|
| Oregon | 1 | 2022 | 140 | 0.050 |
Why?
|
| Viral Load | 2 | 2023 | 3300 | 0.050 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2003 | 249 | 0.050 |
Why?
|
| Odds Ratio | 1 | 2014 | 9849 | 0.050 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 1470 | 0.050 |
Why?
|
| New England | 2 | 2017 | 1022 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 1873 | 0.050 |
Why?
|
| Drug Costs | 1 | 2009 | 1105 | 0.050 |
Why?
|
| Electronic Health Records | 1 | 2018 | 4463 | 0.050 |
Why?
|
| Environmental Monitoring | 1 | 2007 | 1414 | 0.050 |
Why?
|
| Risk Management | 1 | 2005 | 571 | 0.050 |
Why?
|
| Pneumonia, Aspiration | 1 | 2002 | 145 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2020 | 7908 | 0.050 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 2277 | 0.050 |
Why?
|
| Freeze Drying | 1 | 2020 | 98 | 0.050 |
Why?
|
| Complementary Therapies | 1 | 2005 | 486 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 12244 | 0.050 |
Why?
|
| Language | 1 | 2010 | 1471 | 0.050 |
Why?
|
| Health Facilities | 1 | 2005 | 573 | 0.050 |
Why?
|
| Fellowships and Scholarships | 1 | 2009 | 1076 | 0.050 |
Why?
|
| Thorax | 1 | 2023 | 547 | 0.050 |
Why?
|
| Phlebotomy | 1 | 2021 | 141 | 0.050 |
Why?
|
| Cough | 1 | 2023 | 555 | 0.040 |
Why?
|
| Knowledge Bases | 1 | 2020 | 85 | 0.040 |
Why?
|
| Safety Management | 1 | 2005 | 782 | 0.040 |
Why?
|
| Blood Pressure | 2 | 2014 | 8551 | 0.040 |
Why?
|
| Age Factors | 3 | 2021 | 18367 | 0.040 |
Why?
|
| Privacy | 1 | 2022 | 239 | 0.040 |
Why?
|
| Logistic Models | 1 | 2014 | 13409 | 0.040 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2020 | 144 | 0.040 |
Why?
|
| Radiation Injuries | 1 | 2006 | 1178 | 0.040 |
Why?
|
| Obesity | 1 | 2021 | 12742 | 0.040 |
Why?
|
| Vocabulary, Controlled | 1 | 2020 | 170 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2023 | 643 | 0.040 |
Why?
|
| Harm Reduction | 1 | 2020 | 129 | 0.040 |
Why?
|
| Albumins | 1 | 2021 | 569 | 0.040 |
Why?
|
| Safety | 1 | 2004 | 1185 | 0.040 |
Why?
|
| Proteinuria | 1 | 2021 | 657 | 0.040 |
Why?
|
| Plants, Medicinal | 1 | 2019 | 167 | 0.040 |
Why?
|
| Hyperglycemia | 1 | 2007 | 1372 | 0.040 |
Why?
|
| San Francisco | 1 | 2018 | 159 | 0.040 |
Why?
|
| Proteomics | 1 | 2011 | 3637 | 0.040 |
Why?
|
| Trauma Centers | 2 | 2020 | 889 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 2759 | 0.040 |
Why?
|
| Lung | 3 | 2023 | 9852 | 0.040 |
Why?
|
| Coma | 1 | 2002 | 475 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2006 | 1928 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2015 | 4266 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 2 | 2021 | 1978 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 2021 | 527 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2011 | 3680 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 3611 | 0.040 |
Why?
|
| Homocysteine | 1 | 2021 | 647 | 0.040 |
Why?
|
| Qualitative Research | 2 | 2017 | 2682 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 2005 | 1255 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 2001 | 643 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 426 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 4929 | 0.040 |
Why?
|
| Factor VIII | 1 | 2020 | 348 | 0.040 |
Why?
|
| Fetal Heart | 1 | 2019 | 276 | 0.040 |
Why?
|
| Thrombelastography | 1 | 2019 | 163 | 0.040 |
Why?
|
| Aftercare | 1 | 2023 | 866 | 0.040 |
Why?
|
| Animals | 8 | 2020 | 168788 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2023 | 2032 | 0.040 |
Why?
|
| Cerebral Hemorrhage | 1 | 2008 | 2647 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 14726 | 0.040 |
Why?
|
| Fluid Therapy | 1 | 2001 | 593 | 0.040 |
Why?
|
| Atrial Fibrillation | 1 | 2015 | 5034 | 0.040 |
Why?
|
| Rwanda | 1 | 2019 | 703 | 0.040 |
Why?
|
| CpG Islands | 1 | 2021 | 1172 | 0.040 |
Why?
|
| Registries | 3 | 2022 | 8090 | 0.040 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2019 | 571 | 0.040 |
Why?
|
| Markov Chains | 1 | 2020 | 969 | 0.040 |
Why?
|
| Growth Hormone | 1 | 2019 | 703 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 598 | 0.040 |
Why?
|
| Leg Injuries | 1 | 2018 | 178 | 0.030 |
Why?
|
| Potassium | 1 | 2020 | 1336 | 0.030 |
Why?
|
| Morphine | 1 | 2020 | 657 | 0.030 |
Why?
|
| Creatinine | 1 | 2021 | 1919 | 0.030 |
Why?
|
| Popliteal Artery | 1 | 2018 | 317 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 1914 | 0.030 |
Why?
|
| Genomics | 1 | 2011 | 5722 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 20123 | 0.030 |
Why?
|
| Metals | 1 | 2020 | 719 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3747 | 0.030 |
Why?
|
| Limb Salvage | 1 | 2018 | 433 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9438 | 0.030 |
Why?
|
| Catheterization | 1 | 2021 | 1469 | 0.030 |
Why?
|
| Urinalysis | 1 | 2017 | 369 | 0.030 |
Why?
|
| Viral Vaccines | 1 | 2021 | 636 | 0.030 |
Why?
|
| Physical Examination | 1 | 2021 | 1238 | 0.030 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2014 | 77 | 0.030 |
Why?
|
| Blood Proteins | 1 | 2020 | 1123 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 35423 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 9960 | 0.030 |
Why?
|
| France | 2 | 2007 | 517 | 0.030 |
Why?
|
| Ethanol | 1 | 2001 | 1342 | 0.030 |
Why?
|
| Air Pollutants | 1 | 2007 | 2817 | 0.030 |
Why?
|
| Policy | 1 | 2017 | 508 | 0.030 |
Why?
|
| Pregnancy | 2 | 2019 | 29142 | 0.030 |
Why?
|
| Sodium Bicarbonate | 1 | 2013 | 62 | 0.030 |
Why?
|
| Pain, Postoperative | 1 | 2023 | 1640 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2004 | 6485 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 13990 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2023 | 1715 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2005 | 2839 | 0.030 |
Why?
|
| Myocardium | 1 | 2006 | 4776 | 0.030 |
Why?
|
| Liver | 1 | 2008 | 7472 | 0.030 |
Why?
|
| Caregivers | 1 | 2024 | 2094 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2020 | 2309 | 0.030 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 12961 | 0.030 |
Why?
|
| Hydroxocobalamin | 1 | 2011 | 31 | 0.030 |
Why?
|
| Fisheries | 1 | 2012 | 34 | 0.030 |
Why?
|
| Anemia, Sickle Cell | 1 | 2020 | 1018 | 0.030 |
Why?
|
| Xenobiotics | 1 | 2011 | 73 | 0.020 |
Why?
|
| Hematologic Neoplasms | 1 | 2003 | 1831 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2020 | 2486 | 0.020 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 2011 | 71 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2021 | 6461 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2023 | 25618 | 0.020 |
Why?
|
| Asia, Southeastern | 1 | 2011 | 111 | 0.020 |
Why?
|
| Risk | 2 | 2017 | 9685 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 1854 | 0.020 |
Why?
|
| Acid-Base Equilibrium | 1 | 2011 | 185 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2023 | 3313 | 0.020 |
Why?
|
| Half-Life | 1 | 2012 | 659 | 0.020 |
Why?
|
| Drug Substitution | 1 | 2013 | 281 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2013 | 937 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2011 | 683 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2019 | 1365 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 2702 | 0.020 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2014 | 459 | 0.020 |
Why?
|
| Central Nervous System Stimulants | 1 | 2018 | 1148 | 0.020 |
Why?
|
| Alkaloids | 1 | 2011 | 190 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2014 | 1402 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2012 | 348 | 0.020 |
Why?
|
| Ischemia | 1 | 2018 | 1914 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 2011 | 1386 | 0.020 |
Why?
|
| Public Health | 1 | 2021 | 2603 | 0.020 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2011 | 321 | 0.020 |
Why?
|
| Health Personnel | 1 | 2021 | 3216 | 0.020 |
Why?
|
| Rain | 1 | 2007 | 61 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 3646 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39045 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2020 | 2103 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 12355 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2008 | 216 | 0.020 |
Why?
|
| Endemic Diseases | 1 | 2007 | 182 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2015 | 1248 | 0.020 |
Why?
|
| Nitrogen | 1 | 2007 | 344 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2019 | 5096 | 0.020 |
Why?
|
| Electrocardiography | 2 | 2015 | 6442 | 0.020 |
Why?
|
| Epilepsy | 1 | 2002 | 3310 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7784 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 2208 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2007 | 626 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 14556 | 0.020 |
Why?
|
| Acute Disease | 2 | 2006 | 7148 | 0.020 |
Why?
|
| Geography | 1 | 2007 | 670 | 0.020 |
Why?
|
| Comorbidity | 1 | 2020 | 10387 | 0.020 |
Why?
|
| Time Factors | 2 | 2006 | 40063 | 0.020 |
Why?
|
| Chromatography, Gas | 1 | 2005 | 156 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2011 | 3133 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2015 | 2266 | 0.020 |
Why?
|
| Credentialing | 1 | 2005 | 126 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2020 | 4599 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3158 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2007 | 1799 | 0.020 |
Why?
|
| Water Pollutants, Chemical | 1 | 2007 | 311 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2021 | 12718 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 7281 | 0.010 |
Why?
|
| Communication | 1 | 2017 | 3749 | 0.010 |
Why?
|
| Ecosystem | 1 | 2007 | 474 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2007 | 2557 | 0.010 |
Why?
|
| Canada | 1 | 2008 | 2065 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 21824 | 0.010 |
Why?
|
| Mice | 3 | 2020 | 81178 | 0.010 |
Why?
|
| Rats | 2 | 2011 | 24273 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 15525 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3871 | 0.010 |
Why?
|
| Family Health | 1 | 2005 | 1282 | 0.010 |
Why?
|
| Malpractice | 1 | 2005 | 572 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2003 | 1903 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2007 | 5180 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2000 | 11728 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 6172 | 0.010 |
Why?
|
| Severity of Illness Index | 2 | 2007 | 15538 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 13280 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2005 | 2453 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 2886 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2019 | 15294 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 2171 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2011 | 9147 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2007 | 3591 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2000 | 1204 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2008 | 5102 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2007 | 6259 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2007 | 21752 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2006 | 23337 | 0.000 |
Why?
|
| Prognosis | 1 | 2003 | 29050 | 0.000 |
Why?
|
| Incidence | 1 | 2000 | 20945 | 0.000 |
Why?
|